<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>ASTRAZENECA'S EARNINGS RISE</title>
    <meta content="MB225041" name="slug"/>
    <meta content="4" name="publication_day_of_month"/>
    <meta content="5" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Thursday" name="publication_day_of_week"/>
    <meta content="Business/Financial Desk" name="dsk"/>
    <meta content="4" name="print_page_number"/>
    <meta content="C" name="print_section"/>
    <meta content="4" name="print_column"/>
    <meta content="Business" name="online_sections"/>
    <docdata>
      <doc-id id-string="1196787"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <series series.name="WORLD BUSINESS BRIEFING: EUROPE"/>
      <identified-content>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Business</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Business/World Business</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000504T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9C05EFDD1F39F937A35756C0A9669C8B63" item-length="84" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>ASTRAZENECA'S EARNINGS RISE</hl1>
      </hedline>
      <byline class="print_byline">By Andrew Ross Sorkin</byline>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>Europe's largest drug company, AstraZeneca P.L.C., said its first-quarter earnings rose 14 percent. Pretax profit jumped to $1.1 billion from $971 million a year earlier. Dr. Thomas F. W. McKillop, the company's chief executive, said, ''The year has started encouragingly.'' But the company's shares fell over concern that the company does not have another blockbuster drug to replace its ulcer drug Losec, which loses its patent next year.</p>
        <p>Andrew Ross Sorkin (NYT)</p>
      </block>
      <block class="full_text">
        <p>Europe's largest drug company, AstraZeneca P.L.C., said its first-quarter earnings rose 14 percent. Pretax profit jumped to $1.1 billion from $971 million a year earlier. Dr. Thomas F. W. McKillop, the company's chief executive, said, ''The year has started encouragingly.'' But the company's shares fell over concern that the company does not have another blockbuster drug to replace its ulcer drug Losec, which loses its patent next year.</p>
        <p>Andrew Ross Sorkin (NYT)</p>
        <p>WORLD BUSINESS BRIEFING: EUROPE</p>
      </block>
    </body.content>
  </body>
</nitf>
